Study Guide for Lilley's Pharmacology for Canadian Health Care Practice
- 5th Edition - September 1, 2024
- Authors: Kara Sealock, Cydnee Seneviratne
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 8 1 0 2 8 - 9
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 1 1 4 0 - 8
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 1 1 4 1 - 5
Ensure your mastery of need-to-know Canadian pharmacology nursing principles with the Study Guide for Lilley’s Pharmacology for Canadian Health Care Practice, 5th Edition. Design… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteEnsure your mastery of need-to-know Canadian pharmacology nursing principles with the Study Guide for Lilley’s Pharmacology for Canadian Health Care Practice, 5th Edition. Designed to accompany the Lilley’s textbook, this dynamic study guide helps you better understand, retain, and apply the information and concepts from each chapter of the text. Worksheets for each chapter include multiple-choice review questions, critical thinking and application questions, case studies, and a wealth of other learning activities to help you fully prepare for credentialling exams.
Pharmaceutical Abbreviations
Student Study Tips
WORKSHEETS:
PART 1: Pharmacology Basics
1. Nursing Practice in Canada and Drug Therapy
2. Pharmacological Principles
3. Legal and Ethical Considerations
4. Patient Focused Considerations
5. Gene Therapy and Pharmacogenomics
6. Medication Errors: Preventing and Responding
7. Patient Education and Drug Therapy
8. Over-the-Counter Drugs and Natural Health Products
9. Vitamins and Minerals
10. Principles of Drug Administration
PART 2: Drugs Affecting the Central Nervous System
11. Analgesic Drugs
12. General and Local Anaesthetics
13. Central Nervous System Depressants and Muscle Relaxants
14. Central Nervous System Stimulants and Related Drugs
15. Antiepileptic Drugs
16. Antiparkinsonian Drugs
17. Psychotherapeutic Drugs
18. Substance Use Disorder
PART 3: Drugs Affecting the Autonomic Nervous System
19. Adrenergic Drugs
20. Adrenergic-Blocking Drugs
21. Cholinergic Drugs
22. Cholinergic Blocking Drugs
PART 4: Drugs Affecting the Cardiovascular and Renal Systems
23. Antihypertensive Drugs
24. Antianginal Drugs
25. Heart Failure Drugs
26. Diuretic Drugs
27. Antidysrhythmic Drugs
28. Coagulation Modifier Drugs
29. Antilipemic Drugs
30. Fluids and Electrolytes
PART 5: Drugs Affecting the Endocrine System
31. Pituitary Drugs
32. Thyroid and Antithyroid Drugs
33. Antidiabetic Drugs
34. Adrenal Drugs
35. Women's Health Drugs
36. Men's Health Drugs
PART 6: Drugs Affecting the Respiratory System
37. Antihistamines, Decongestants, Antitussives, and Expectorants
38. Respiratory Drugs
PART 7: Drugs Affecting the Gastrointestinal System and Nutrition
39. Acid-Controlling Drugs
40. Antidiarrheal Drugs and Laxatives
41. Antiemetic and Antinausea Drugs
42. Nutritional Supplements
PART 8: Anti-Infective and Anti-Inflammatory Drugs
43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines
44. Antibiotics Part 2: Aminoglycosides, Fluoroquinalones, and Other Drugs
45. Antiviral Drugs
46. Antitubercular Drugs
47. Antifungal Drugs
48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs
49. Anti-Inflammatory and Antigout Drugs
PART 9: Immune and Biological Modifiers and Chemotherapeutic Drugs
50. Immunosuppressant Drugs
51. Immunizing Drugs and Pandemic Preparedness
52. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle - Specific Drugs
53. Antineoplastic Drugs Part 2: Cell Cycle - Nonspecific and Miscellaneous Drugs
54. Biological Response - Modifying Drugs and Antirheumatic Drugs
PART 10: Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs
55. Anemia Drugs
56. Dermatological Drugs
57. Ophthalmic Drugs
58. Otic Drugs
Overview of Dosage Calculations
Answers (to worksheets and overview of dosage calculations)
Student Study Tips
WORKSHEETS:
PART 1: Pharmacology Basics
1. Nursing Practice in Canada and Drug Therapy
2. Pharmacological Principles
3. Legal and Ethical Considerations
4. Patient Focused Considerations
5. Gene Therapy and Pharmacogenomics
6. Medication Errors: Preventing and Responding
7. Patient Education and Drug Therapy
8. Over-the-Counter Drugs and Natural Health Products
9. Vitamins and Minerals
10. Principles of Drug Administration
PART 2: Drugs Affecting the Central Nervous System
11. Analgesic Drugs
12. General and Local Anaesthetics
13. Central Nervous System Depressants and Muscle Relaxants
14. Central Nervous System Stimulants and Related Drugs
15. Antiepileptic Drugs
16. Antiparkinsonian Drugs
17. Psychotherapeutic Drugs
18. Substance Use Disorder
PART 3: Drugs Affecting the Autonomic Nervous System
19. Adrenergic Drugs
20. Adrenergic-Blocking Drugs
21. Cholinergic Drugs
22. Cholinergic Blocking Drugs
PART 4: Drugs Affecting the Cardiovascular and Renal Systems
23. Antihypertensive Drugs
24. Antianginal Drugs
25. Heart Failure Drugs
26. Diuretic Drugs
27. Antidysrhythmic Drugs
28. Coagulation Modifier Drugs
29. Antilipemic Drugs
30. Fluids and Electrolytes
PART 5: Drugs Affecting the Endocrine System
31. Pituitary Drugs
32. Thyroid and Antithyroid Drugs
33. Antidiabetic Drugs
34. Adrenal Drugs
35. Women's Health Drugs
36. Men's Health Drugs
PART 6: Drugs Affecting the Respiratory System
37. Antihistamines, Decongestants, Antitussives, and Expectorants
38. Respiratory Drugs
PART 7: Drugs Affecting the Gastrointestinal System and Nutrition
39. Acid-Controlling Drugs
40. Antidiarrheal Drugs and Laxatives
41. Antiemetic and Antinausea Drugs
42. Nutritional Supplements
PART 8: Anti-Infective and Anti-Inflammatory Drugs
43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines
44. Antibiotics Part 2: Aminoglycosides, Fluoroquinalones, and Other Drugs
45. Antiviral Drugs
46. Antitubercular Drugs
47. Antifungal Drugs
48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs
49. Anti-Inflammatory and Antigout Drugs
PART 9: Immune and Biological Modifiers and Chemotherapeutic Drugs
50. Immunosuppressant Drugs
51. Immunizing Drugs and Pandemic Preparedness
52. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle - Specific Drugs
53. Antineoplastic Drugs Part 2: Cell Cycle - Nonspecific and Miscellaneous Drugs
54. Biological Response - Modifying Drugs and Antirheumatic Drugs
PART 10: Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs
55. Anemia Drugs
56. Dermatological Drugs
57. Ophthalmic Drugs
58. Otic Drugs
Overview of Dosage Calculations
Answers (to worksheets and overview of dosage calculations)
- No. of pages: 248
- Language: English
- Edition: 5
- Published: September 1, 2024
- Imprint: Elsevier
- Paperback ISBN: 9780323810289
KS
Kara Sealock
Dr. Kara Sealock is a tenured, senior instructor in the Faculty of Nursing, University of Calgary with a focus in adult education. She has extensive experience teaching students from years 1 to 4 in both clinical and theory. Dr. Sealock is passionate about pathophysiology, assessment, and pharmacology content addressing populations across the lifespan, supporting students as they transition from student to practitioner, and student success on NCLEX-RN.
To the educator role, Dr. Sealock brings strong clinical nursing experience in adult critical care (ICU/CCU), medical-surgical, gerontology, and clinical research (cardiovascular and endocrinology).
Dr. Sealock’s research interests include adult learning with specific attention to cognitive levels of learning in clinical and theoretical environments (critical thinking/clinical judgement), student success on NCLEX-RN and faculty development, relational inquiry, and empathy. She has presented at the local, provincial, and national level.
Dr. Sealock has been an NCSBN item writer for the NCLEX and NGN. She is also the NGN faculty training lead at the University of Calgary. Along with being one of the co-authors of our Lilley’s Pharmacology for Canadian Health Care Practice, Dr. Sealock serves as Elsevier’s Canadian NCLEX-NGN subject matter expert.
Dr. Sealock holds the 2019 Faculty of Nursing, Pursuit of Excellence Award- Committee’s Choice, and was recently awarded the 2022/23 Pat Griffin Research Grant by the Canadian Association of Schools of Nursing (CASN).
Affiliations and expertise
Senior Instructor ,Faculty of Nursing,University of Calgary ,Calgary, Alberta,CanadaCS
Cydnee Seneviratne
Cydnee Seneviratne, RN, BScN, MN, PhD
Affiliations and expertise
University of Calgary, Faculty of Nursing
Calgary, Alberta